Salma Mahmoud

A study shows the devices ability to lower IOP and their associations with the need for additional interventions.

Efficacy and safety of 3 different doses of atropine sulfate (DE-127) ophthalmic solution at slowing myopia progression.

The test requires a 1 mL sample.

A study shows the 1 year stability of a fluid-filled intraocular lens that changes power.

Switch from aflibercept resulted in significant central retinal thickness reductions and visual acuity improvements.

A study shows the effect of ab-interno canaloplasty with iTrack for patients with glaucoma.

A novel gene therapy approach may manage MT-ND4 Leber hereditary optic neuropathy.

Earlier treatment with aflibercept improved outcomes in diabetic macular edema.

An AAO presentation shows the potential of a glaucoma medication that may require fewer drops than timolol.

Researchers noted elevated rates of lacrimal drainage obstruction and lid malposition among patients using glaucoma drops.

Complications were noted in fewer than 1% of eyes.

Researchers show visual outcomes of patients with neurofibromatosis type 1 and optic pathways gliomas.

A presentation at the AAO demonstrated the utility of big data to understand real-world care of rare ophthalmic conditions.

The predictive factors were found using aqueous humor immune mediator profiles.

Presenters reviewed pediatric patients who wore prisms for an 8-week trial.

Rates for late complications and reoperations after 5 years were similar between trabeculectomy and tube shunts.